The goal of this study was to compare the clinical efficacy , tolerability and safety of artesunate-amodiaquine ( ASAQ ) , artemether-lumefantrine ( AL ) and dihydroartemisinin piperaquine ( DHAP ) among children aged less than ten years in two malaria-endemic ecological regions of Cameroon .